Chinese drugmakers developing generic drugs of Novo Nordisks Ozempic - Reuters
| LP6 Stock | EUR 3.26 0.04 1.24% |
Roughly 53% of LIVZON PHARMAC's stockholders are presently thinking to get in. The analysis of current outlook of investing in LIVZON PHARMAC GRP suggests that some traders are interested regarding LIVZON PHARMAC's prospects. The current market sentiment, together with LIVZON PHARMAC's historical and current headlines, can help investors time the market. In addition, many technical investors use LIVZON PHARMAC GRP stock news signals to limit their universe of possible portfolio assets.
LIVZON PHARMAC stock news, alerts, and headlines are usually related to its technical, predictive, social, and fundamental indicators. It can reflect on the current distribution of LIVZON daily returns and investor perception about the current price of LIVZON PHARMAC GRP as well as its diversification or hedging effects on your existing portfolios.
LIVZON |
Chinese drugmakers developing generic drugs of Novo Nordisks Ozempic Reuters
Read at news.google.com
 |
LIVZON PHARMAC Fundamental Analysis
We analyze LIVZON PHARMAC's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of LIVZON PHARMAC using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of LIVZON PHARMAC based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Probability Of Bankruptcy
Probability Of Bankruptcy Comparative Analysis
LIVZON PHARMAC is currently under evaluation in probability of bankruptcy category among its peers. Probability Of Bankruptcy is a relative measure of the likelihood of financial distress. For stocks, the Probability Of Bankruptcy is the normalized value of Z-Score. For funds and ETFs, it is derived from a multi-factor model developed by Macroaxis. The score is used to predict the probability of a firm or a fund experiencing financial distress within the next 24 months. Unlike Z-Score, Probability Of Bankruptcy is the value between 0 and 100, indicating the firm's actual probability it will be financially distressed in the next 2 fiscal years.
LIVZON PHARMAC GRP Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with LIVZON PHARMAC stock to make a market-neutral strategy. Peer analysis of LIVZON PHARMAC could also be used in its relative valuation, which is a method of valuing LIVZON PHARMAC by comparing valuation metrics with similar companies.
Peers
LIVZON PHARMAC Related Equities
| 2DG | SIVERS SEMICONDUCTORS | 6.25 | ||||
| 3RKU | RYOHIN UNSPADR1 | 3.92 | ||||
| MEL | Meli Hotels | 2.87 | ||||
| HEI | Heidelberg Materials | 2.63 | ||||
| IDP | Biogen | 1.49 | ||||
| 8SP | Superior Plus | 0.91 | ||||
| VUSA | Vanguard Funds | 0.90 | ||||
| CJH | CanSino Biologics | 0.50 |
Complementary Tools for LIVZON Stock analysis
When running LIVZON PHARMAC's price analysis, check to measure LIVZON PHARMAC's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy LIVZON PHARMAC is operating at the current time. Most of LIVZON PHARMAC's value examination focuses on studying past and present price action to predict the probability of LIVZON PHARMAC's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move LIVZON PHARMAC's price. Additionally, you may evaluate how the addition of LIVZON PHARMAC to your portfolios can decrease your overall portfolio volatility.
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
| Bonds Directory Find actively traded corporate debentures issued by US companies | |
| Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing |